Publications by authors named "Thomas Kaley"

48Publications

Challenges in the Treatment of Newly Diagnosed and Recurrent Primary Central Nervous System Lymphoma.

J Natl Compr Canc Netw 2020 11 2;18(11):1571-1578. Epub 2020 Nov 2.

Center for CNS Lymphoma, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article and Find Full Text PDF
November 2020

Value of [F]-FDG positron emission tomography in patients with recurrent glioblastoma receiving bevacizumab.

Neurooncol Adv 2020 Jan-Dec;2(1):vdaa050. Epub 2020 Apr 15.

Department of Radiology, Neuroradiology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

View Article and Find Full Text PDF
April 2020

Evaluation of toxicity of carmustine with or without bevacizumab in patients with recurrent or progressive high grade gliomas.

J Neurooncol 2019 Oct 20;145(1):57-63. Epub 2019 Aug 20.

Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA.

View Article and Find Full Text PDF
October 2019

Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma.

J Neurooncol 2019 Sep 19;144(2):403-407. Epub 2019 Jul 19.

Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article and Find Full Text PDF
September 2019

BRAF Inhibition in -Mutant Gliomas: Results From the VE-BASKET Study.

J Clin Oncol 2018 12 23;36(35):3477-3484. Epub 2018 Oct 23.

Thomas Kaley, Lisa M. DeAngelis, Jose Baselga, and David M. Hyman, Memorial Sloan Kettering Cancer Center; Thomas Kaley, Lisa M. DeAngelis, Jose Baselga, and David M. Hyman, Weill Cornell Medical College, New York; Igor Puzanov, Roswell Park Cancer Institute, Buffalo, NY; Mehdi Touat and Antoine Hollebecque, Institut Gustave Roussy, Villejuif; Franck Bielle, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Paris; Florence Joly, Centre François Baclesse, Caen; Jean-Yves Blay, Centre Léon Bérard, Lyon, France; Vivek Subbiah, MD Anderson Cancer Center, Houston, TX; Jordi Rodon, Vall d'Hebron University Hospital, Barcelona, Spain; A. Craig Lockhart, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL; Vicki Keedy, Vanderbilt University Medical Center, Nashville, TN; Ralf-Dieter Hofheinz, Universitätsmedizin Mannheim, Mannheim; Jurgen Wolf, Universitätsklinikum Köln, Cologne, Germany; Ian Chau, The Royal Marsden National Health Service Foundation Trust, London, United Kingdom; Noopur S. Raje, Massachusetts General Hospital, Boston, MA; Martina Makrutzki, F Hoffmann-La Roche, Basel, Switzerland; Todd Riehl, Genentech, South San Francisco, CA; and Bethany Pitcher, F Hoffmann-La Roche, Mississauga, Ontario, Canada.

View Article and Find Full Text PDF
December 2018

Rapid infusion rituximab is well tolerated in patients with primary CNS lymphoma.

CNS Oncol 2018 07 17;7(3):CNS19. Epub 2018 Sep 17.

Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.

View Article and Find Full Text PDF
July 2018

Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas.

J Clin Oncol 2018 06 23;36(17):1702-1709. Epub 2018 Apr 23.

Antonio Omuro, University of Miami, Miami, FL; Kathryn Beal, Robert J. Young, Thomas J. Kaley, Lisa M. DeAngelis, Mariza Daras, Igor T. Gavrilovic, Ingo Mellinghoff, Eli L. Diamond, Andrew McKeown, Malbora Manne, Andrew Caterfino, Krishna Patel, Philip Gutin, Viviane Tabar, Debyani Chakravarty, Timothy A. Chan, Cameron W. Brennan, and Elena Pentsova, Memorial Sloan Kettering Cancer Center; Rashida A. Karmali, Tactical Therapeutics, Inc, New York; Katharine McNeill, Montefiore Medical Center, Bronx, NY; Alissa Thomas, University of Vermont, Burlington, VT; Xuling Lin, National Neuroscience Institute, Singapore; Robert Terziev, University Hospital, Zurich, Switzerland; Linda Bavisotto, Porta Clinica PLLC, Seattle, WA; Greg Gorman, Samford University McWhorter School of Pharmacy, Birmingham, AL; Michael Lamson, Nuventra Pharma Sciences, Durham, NC; and Elizabeth Garrett-Mayer, Medical University of South Carolina, Charleston, SC.

View Article and Find Full Text PDF
June 2018

Radiographic patterns of recurrence and pathologic correlation in malignant gliomas treated with bevacizumab.

CNS Oncol 2018 01 1;7(1):7-13. Epub 2018 Feb 1.

Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article and Find Full Text PDF
January 2018